Geoff Meacham's
Stock Forecasts
37.5%
6/16 win trades
Price targets by Geoff Meacham
| Company name & ticker | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|
 Lyell Immunopharma, Inc. LYEL | 11 months ago | $1 -90.76% downside | $0.95 | TheFly | Previous targets (0) |
 Amylyx Pharmaceuticals, Inc. AMLX | 11 months ago | $10 27.55% upside | $4.53 | StreetInsider | Previous targets (0) |
 AbbVie Inc. ABBV | 11 months ago | $195 -5.65% downside | $188.57 | StreetInsider | Previous targets (0) |
 Vertex Pharmaceuticals Incorporated VRTX | 12 months ago | $541 38.54% upside | $482.12 | TheFly | Previous targets (0) |
 Eli Lilly and Company LLY | about 1 year ago | $1,150 64.63% upside | $845.31 | StreetInsider | Previous targets (0) |
 Regeneron Pharmaceuticals, Inc. REGN | about 1 year ago | $805 40.05% upside | $1,077.48 | TheFly | Previous targets (0) |
 Merck & Co., Inc. MRK | about 1 year ago | $145 70.72% upside | $115.21 | TheFly | Previous targets (0) |
Other analysts covering same stocks
Tobias Gottschalt
Independent Research
100%
win rate
Covering:
Luisa Hector
Berenberg Bank
100%
win rate
Covering:
Andrew Galler
Wolfe Research
100%
win rate
Daniel Busby
RBC Capital
100%
win rate
Geoff Porges
Leerink Partners
100%
win rate
Thomas Yeh
Morgan Stanley
75%
win rate
Navin Jacob
UBS
75%
win rate
Steve Scala
Cowen & Co.
66.67%
win rate
Olivia Brayer
Cantor Fitzgerald
60%
win rate
Steve Chesney
Atlantic Equities
60%
win rate